This phase 3 trial is testing whether liver surgery followed by two drugs (atezolizumab and bevacizumab) can help people with liver cancer that has spread into veins. The study includes 501 participants who have not had prior treatment. The goal is to see if this approach delays …
Phase: PHASE3 • Sponsor: Jia Fan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC